Executive Director Bristol-Myers Squibb Company Skillman, New Jersey
Join Otilia M. Koo, Ph.D., Abstract Screening Committee Chair, and several authors in Forum #2 in the Solution Center for a conversation about posters she is especially excited about.
T0930-01-02, A Physical Picture for the Dissolution Process of Copovidone ASDs, Alexandru Deac, Ph.D. Candidate, Purdue University
T0930-06-35, Automated Adaptive Perfusion: A Novel In Vitro Drug Release Testing System for Complex Drug Products, Darby Kozak, Ph.D., US Food and Drug Administration
M1030-07-41, Biorelevant Dissolution Method Considerations for the Appropriate Evaluation of Amorphous Solid Dispersions: Are Two Stages Necessary? Zhaoxian (George) Wang, Ph.D., University of Kansas
T1130-08-47, Building Fundamental Understanding of Drug Release Mechanisms via Release of Functional Excipients, Weili Wang, MS, AbbVie Inc.
W1130-03-17, Enabling Oral Delivery of Exenatide by Designing Phospholipid Complexes for Self-nanoemulsifying Drug Delivery Systems, Ramakrishnan Venkatasubramanian, MS, University of Copenhagen
T1130-06-33, Midazolam Buccal Films: Development and Characterization for Palliative Care, Sui Yung Chan, MBA, Ph.D., National University of Singapore
